Maravai LifeSciences

In 2024, Maravai LifeSciences reported total carbon emissions of about 76,575,040 kg CO2e. This included Scope 1 emissions of 862,580 kg CO2e, Scope 2 market-based emissions of 2,208,570 kg CO2e, and Scope 3 emissions of 73,503,890 kg CO2e. Key contributors to Scope 3 emissions were purchased goods and services at 56,213,130 kg CO2e and capital goods at 10,027,390 kg CO2e.

Looking back, in 2023, the company's total emissions were approximately 21,800,000 kg CO2e. This comprised Scope 1 emissions of 736,590 kg CO2e, Scope 2 market-based emissions of 1,993,000 kg CO2e, and Scope 3 emissions of about 19,431,000 kg CO2e. In 2022, Maravai LifeSciences reported Scope 1 emissions of 377,000 kg CO2e and Scope 2 market-based emissions of 1,309,000 kg CO2e. For 2021, Scope 1 emissions were 330,000 kg CO2e and Scope 2 market-based emissions were 1,103,000 kg CO2e. Scope 3 data was not available for 2021 and 2022.

Maravai LifeSciences has committed to achieving Net-Zero emissions and its near-term Science Based Targets initiative (SBTi) target status is "Committed," as of October 2025. These commitments demonstrate their dedication to reducing their climate impact within the research and development services industry.